{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T20:52:41Z","timestamp":1783543961185,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Amyloid PET\/CT is essential for quantifying amyloid-beta (A\u03b2) deposition in Alzheimer\u2019s disease (AD), with the Centiloid (CL) scale standardizing measurements across imaging centers. However, MRI-based CL pipelines face challenges: high cost, contraindications, and patient burden. To address these challenges, we developed a deep learning-based CT parcellation pipeline calibrated to the standard CL scale using CT images from PET\/CT scans and evaluated its performance relative to standard pipelines.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A total of 306 participants (23 young controls [YCs] and 283 patients) underwent 18\u00a0F-florbetaben (FBB) PET\/CT and MRI. Based on visual assessment, 207 patients were classified as A\u03b2-positive and 76 as A\u03b2-negative. PET images were processed using the CT parcellation pipeline and compared to FreeSurfer (FS) and standard pipelines. Agreement was assessed via regression analyses. Effect size, variance, and ROC analyses were used to compare pipelines and determine the optimal CL threshold relative to visual A\u03b2 assessment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The CT parcellation showed high concordance with the FS and provided reliable CL quantification (R\u00b2 = 0.99). Both pipelines demonstrated similar variance in YCs and effect sizes between YCs and ADCI. ROC analyses confirmed comparable accuracy and similar CL thresholds, supporting CT parcellation as a viable MRI-free alternative.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our findings indicate that the CT parcellation pipeline achieves a level of accuracy similar to FS in CL quantification, demonstrating its reliability as an MRI-free alternative. In PET\/CT, CT and PET are acquired sequentially within the same session on a shared bed and headrest, which helps maintain consistent positioning and adequate spatial alignment, reducing registration errors and supporting more reliable and precise quantification.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13195-025-01860-1","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:22:05Z","timestamp":1759227725000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Centiloid values from deep learning-based CT parcellation: a valid alternative to freesurfer"],"prefix":"10.1186","volume":"17","author":[{"given":"Yeo Jun","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungbeom","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangwon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunkeong","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyobin","family":"Choo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daesung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunkyung","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjae","family":"So","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hosung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seongjin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongwoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-gun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongho","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Joo","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mijin","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"issue":"7","key":"1860_CR1","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.2967\/jnumed.116.188029","volume":"58","author":"AA Lammertsma","year":"2017","unstructured":"Lammertsma AA. Forward to the past: the case for quantitative PET imaging. J Nucl Med. 2017;58(7):1019\u201324.","journal-title":"J Nucl Med"},{"issue":"3","key":"1860_CR2","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jagp.2012.11.016","volume":"21","author":"PB Rosenberg","year":"2013","unstructured":"Rosenberg PB, Wong DF, Edell SL, Ross JS, Joshi AD, Brasic JR, et al. Cognition and amyloid load in alzheimer disease imaged with Florbetapir F 18(AV-45) positron emission tomography. Am J Geriatr Psychiatry. 2013;21(3):272\u20138.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"1","key":"1860_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13195-019-0577-x","volume":"12","author":"SE Kim","year":"2020","unstructured":"Kim SE, Lee B, Park S, Cho SH, Kim SJ, Kim Y, et al. Clinical significance of focal ss-amyloid deposition measured by (18)F-flutemetamol PET. Alzheimers Res Ther. 2020;12(1):6.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"1860_CR4","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","volume":"8","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Chen H, Li R, Sterling K, Song W. Amyloid beta-based therapy for alzheimer\u2019s disease: challenges, successes and future. Signal Transduct Target Ther. 2023;8(1):248.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"1860_CR5","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s13139-024-00848-3","volume":"58","author":"KW Park","year":"2024","unstructured":"Park KW. Anti-amyloid antibody therapies for alzheimer\u2019s disease. Nucl Med Mol Imaging. 2024;58(4):227\u201336.","journal-title":"Nucl Med Mol Imaging"},{"issue":"1","key":"1860_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2014.07.003","volume":"11","author":"WE Klunk","year":"2015","unstructured":"Klunk WE, Koeppe RA, Price JC, Benzinger TL, Devous MD, Sr., Jagust WJ, et al. The centiloid project: standardizing quantitative amyloid plaque estimation by PET. Alzheimers Dement. 2015;11(1):1\u2013e151.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"1860_CR7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.acvd.2018.11.001","volume":"112","author":"C Delhomme","year":"2019","unstructured":"Delhomme C, Njeim M, Varlet E, Pechmajou L, Benameur N, Cassan P, et al. Automated external defibrillator use in out-of-hospital cardiac arrest: current limitations and solutions. Arch Cardiovasc Dis. 2019;112(3):217\u201322.","journal-title":"Arch Cardiovasc Dis"},{"issue":"2","key":"1860_CR8","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/alz.12668","volume":"19","author":"SM Landau","year":"2023","unstructured":"Landau SM, Ward TJ, Murphy A, Iaccarino L, Harrison TM, La Joie R, et al. Quantification of amyloid beta and tau PET without a structural MRI. Alzheimers Dement. 2023;19(2):444\u201355.","journal-title":"Alzheimers Dement"},{"key":"1860_CR9","doi-asserted-by":"publisher","first-page":"118775","DOI":"10.1016\/j.neuroimage.2021.118775","volume":"246","author":"L Iaccarino","year":"2022","unstructured":"Iaccarino L, La Joie R, Koeppe R, Siegel BA, Hillner BE, Gatsonis C, et al. rPOP: robust PET-only processing of community acquired heterogeneous amyloid-PET data. NeuroImage. 2022;246:118775.","journal-title":"NeuroImage"},{"issue":"Suppl 1","key":"1860_CR10","doi-asserted-by":"publisher","first-page":"S159","DOI":"10.1016\/j.neurobiolaging.2014.04.033","volume":"36","author":"P Bourgeat","year":"2015","unstructured":"Bourgeat P, Villemagne VL, Dore V, Brown B, Macaulay SL, Martins R, et al. Comparison of MR-less PiB SUVR quantification methods. Neurobiol Aging. 2015;36(Suppl 1):S159\u201366.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"1860_CR11","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13195-022-01099-0","volume":"14","author":"SJ Kim","year":"2022","unstructured":"Kim SJ, Ham H, Park YH, Choe YS, Kim YJ, Jang H, et al. Development and clinical validation of CT-based regional modified centiloid method for amyloid PET. Alzheimers Res Ther. 2022;14(1):157.","journal-title":"Alzheimers Res Ther"},{"key":"1860_CR12","doi-asserted-by":"publisher","first-page":"118606","DOI":"10.1016\/j.neuroimage.2021.118606","volume":"244","author":"M Srikrishna","year":"2021","unstructured":"Srikrishna M, Pereira JB, Heckemann RA, Volpe G, van Westen D, Zettergren A, et al. Deep learning from MRI-derived labels enables automatic brain tissue classification on human brain CT. NeuroImage. 2021;244:118606.","journal-title":"NeuroImage"},{"key":"1860_CR13","doi-asserted-by":"publisher","first-page":"120922","DOI":"10.1016\/j.neuroimage.2024.120922","volume":"303","author":"S Huisman","year":"2024","unstructured":"Huisman S, Maspero M, Philippens M, Verhoeff J, David S. Validation of synthseg segmentation performance on CT using paired MRI from radiotherapy patients. NeuroImage. 2024;303:120922.","journal-title":"NeuroImage"},{"issue":"8","key":"1860_CR14","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1007\/s00259-025-07132-2","volume":"52","author":"D Kim","year":"2025","unstructured":"Kim D, Choo K, Lee S, Kang S, Yun M, Yang J. Automated quantification of brain PET in PET\/CT using deep learning-based CT-to-MR translation: a feasibility study. Eur J Nucl Med Mol Imaging. 2025;52(8):2959\u201367.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1860_CR15","doi-asserted-by":"crossref","unstructured":"Choo K, Joo J, Lee S, Kim D, Lim H, Kim D et al. Deep learning-based precontrast CT parcellation for MRI-free brain amyloid PET quantification. Clin Nucl Med. 2025;50(5):e262-e270.","DOI":"10.1097\/RLU.0000000000005652"},{"issue":"3","key":"1860_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr., Kawas CH, et al. The diagnosis of dementia due to alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s association workgroups on diagnostic guidelines for alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):263\u20139.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"1860_CR17","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1001\/archneur.56.3.303","volume":"56","author":"RC Petersen","year":"1999","unstructured":"Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56(3):303\u20138.","journal-title":"Arch Neurol"},{"issue":"6","key":"1860_CR18","doi-asserted-by":"publisher","first-page":"900","DOI":"10.2967\/jnumed.115.161927","volume":"57","author":"J Seibyl","year":"2016","unstructured":"Seibyl J, Catafau AM, Barthel H, Ishii K, Rowe CC, Leverenz JB, et al. Impact of training method on the robustness of the visual assessment of 18F-Florbetaben PET scans: results from a phase-3 study. J Nucl Med. 2016;57(6):900\u20136.","journal-title":"J Nucl Med"},{"issue":"1","key":"1860_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40336-015-0102-6","volume":"3","author":"O Sabri","year":"2015","unstructured":"Sabri O, Seibyl J, Rowe C, Barthel H. Beta-amyloid imaging with florbetaben. Clin Transl Imaging. 2015;3(1):13\u201326.","journal-title":"Clin Transl Imaging"},{"issue":"1","key":"1860_CR20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13195-021-00836-1","volume":"13","author":"SK Royse","year":"2021","unstructured":"Royse SK, Minhas DS, Lopresti BJ, Murphy A, Ward T, Koeppe RA, et al. Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach. Alzheimers Res Ther. 2021;13(1):99.","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"1860_CR21","doi-asserted-by":"publisher","first-page":"567","DOI":"10.2967\/jnumed.114.148981","volume":"56","author":"SM Landau","year":"2015","unstructured":"Landau SM, Fero A, Baker SL, Koeppe R, Mintun M, Chen K, et al. Measurement of longitudinal beta-amyloid change with 18F-florbetapir PET and standardized uptake value ratios. J Nucl Med. 2015;56(4):567\u201374.","journal-title":"J Nucl Med"},{"issue":"8","key":"1860_CR22","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.jalz.2015.02.004","volume":"11","author":"O Sabri","year":"2015","unstructured":"Sabri O, Sabbagh MN, Seibyl J, Barthel H, Akatsu H, Ouchi Y, et al. Florbetaben PET imaging to detect amyloid beta plaques in alzheimer\u2019s disease: phase 3 study. Alzheimers Dement. 2015;11(8):964\u201374.","journal-title":"Alzheimers Dement"},{"issue":"12","key":"1860_CR23","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1007\/s00259-017-3749-6","volume":"44","author":"CC Rowe","year":"2017","unstructured":"Rowe CC, Dore V, Jones G, Baxendale D, Mulligan RS, Bullich S, et al. (18)F-Florbetaben PET beta-amyloid binding expressed in centiloids. Eur J Nucl Med Mol Imaging. 2017;44(12):2053\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"1860_CR24","doi-asserted-by":"publisher","first-page":"14950","DOI":"10.1038\/s41598-020-70978-z","volume":"10","author":"SH Cho","year":"2020","unstructured":"Cho SH, Choe YS, Park S, Kim YJ, Kim HJ, Jang H, et al. Appropriate reference region selection of (18)F-florbetaben and (18)F-flutemetamol beta-amyloid PET expressed in centiloid. Sci Rep. 2020;10(1):14950.","journal-title":"Sci Rep"},{"issue":"7","key":"1860_CR25","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1007\/s00259-020-05174-2","volume":"48","author":"LE Collij","year":"2021","unstructured":"Collij LE, Salvado G, Shekari M, Lopes Alves I, Reimand J, Wink AM, et al. Visual assessment of [(18)F]flutemetamol PET images can detect early amyloid pathology and grade its extent. Eur J Nucl Med Mol Imaging. 2021;48(7):2169\u201382.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"1860_CR26","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1002\/alz.12886","volume":"19","author":"LE Collij","year":"2023","unstructured":"Collij LE, Salvado G, de Wilde A, Altomare D, Shekari M, Gispert JD, et al. Quantification of [(18) f]florbetaben amyloid-PET imaging in a mixed memory clinic population: the ABIDE project. Alzheimers Dement. 2023;19(6):2397\u2013407.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"1860_CR27","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jalz.2018.09.001","volume":"15","author":"R La Joie","year":"2019","unstructured":"La Joie R, Ayakta N, Seeley WW, Borys E, Boxer AL, DeCarli C, et al. Multisite study of the relationships between antemortem [(11)C]PIB-PET centiloid values and postmortem measures of alzheimer\u2019s disease neuropathology. Alzheimers Dement. 2019;15(2):205\u201316.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1860_CR28","doi-asserted-by":"publisher","first-page":"110","DOI":"10.2967\/jnumed.124.268119","volume":"66","author":"LE Collij","year":"2025","unstructured":"Collij LE, Bischof GN, Altomare D, Bader I, Battle M, Vallez Garcia D, et al. Quantification supports amyloid PET visual assessment of challenging cases: results from the AMYPAD diagnostic and patient management study. J Nucl Med. 2025;66(1):110\u20136.","journal-title":"J Nucl Med"},{"issue":"1","key":"1860_CR29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13195-020-00587-5","volume":"12","author":"S Amadoru","year":"2020","unstructured":"Amadoru S, Dore V, McLean CA, Hinton F, Shepherd CE, Halliday GM, et al. Comparison of amyloid PET measured in centiloid units with neuropathological findings in alzheimer\u2019s disease. Alzheimers Res Ther. 2020;12(1):22.","journal-title":"Alzheimers Res Ther"},{"key":"1860_CR30","doi-asserted-by":"publisher","first-page":"117821","DOI":"10.1016\/j.neuroimage.2021.117821","volume":"232","author":"PJ Markiewicz","year":"2021","unstructured":"Markiewicz PJ, Matthews JC, Ashburner J, Cash DM, Thomas DL, De Vita E, et al. Uncertainty analysis of MR-PET image registration for precision neuro-PET imaging. NeuroImage. 2021;232:117821.","journal-title":"NeuroImage"},{"issue":"9","key":"1860_CR31","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.jalz.2014.09.004","volume":"11","author":"ME Schmidt","year":"2015","unstructured":"Schmidt ME, Chiao P, Klein G, Matthews D, Thurfjell L, Cole PE, et al. The influence of biological and technical factors on quantitative analysis of amyloid PET: points to consider and recommendations for controlling variability in longitudinal data. Alzheimers Dement. 2015;11(9):1050\u201368.","journal-title":"Alzheimers Dement"},{"issue":"11","key":"1860_CR32","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.2967\/jnumed.115.171652","volume":"57","author":"AM Catafau","year":"2016","unstructured":"Catafau AM, Bullich S, Seibyl JP, Barthel H, Ghetti B, Leverenz J, et al. Cerebellar amyloid-beta plaques: how frequent are they, and do they influence 18F-Florbetaben SUV ratios?? J Nucl Med. 2016;57(11):1740\u20135.","journal-title":"J Nucl Med"},{"issue":"8","key":"1860_CR33","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.2967\/jnumed.116.187351","volume":"58","author":"S Bullich","year":"2017","unstructured":"Bullich S, Villemagne VL, Catafau AM, Jovalekic A, Koglin N, Rowe CC, et al. Optimal reference region to measure longitudinal amyloid-beta change with (18)F-Florbetaben PET. J Nucl Med. 2017;58(8):1300\u20136.","journal-title":"J Nucl Med"},{"key":"1860_CR34","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.neuroimage.2016.08.056","volume":"144","author":"CG Schwarz","year":"2017","unstructured":"Schwarz CG, Senjem ML, Gunter JL, Tosakulwong N, Weigand SD, Kemp BJ, et al. Optimizing PiB-PET SUVR change-over-time measurement by a large-scale analysis of longitudinal reliability, plausibility, separability, and correlation with MMSE. NeuroImage. 2017;144:113\u201327.","journal-title":"NeuroImage"},{"issue":"12","key":"1860_CR35","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1007\/s00234-021-02761-4","volume":"63","author":"AL Kaipainen","year":"2021","unstructured":"Kaipainen AL, Pitkanen J, Haapalinna F, Jaaskelainen O, Jokinen H, Melkas S, et al. A novel CT-based automated analysis method provides comparable results with MRI in measuring brain atrophy and white matter lesions. Neuroradiology. 2021;63(12):2035\u201346.","journal-title":"Neuroradiology"},{"issue":"1","key":"1860_CR36","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/alz.13445","volume":"20","author":"M Srikrishna","year":"2024","unstructured":"Srikrishna M, Ashton NJ, Moscoso A, Pereira JB, Heckemann RA, van Westen D, et al. CT-based volumetric measures obtained through deep learning: association with biomarkers of neurodegeneration. Alzheimers Dement. 2024;20(1):629\u201340.","journal-title":"Alzheimers Dement"},{"issue":"9","key":"1860_CR37","doi-asserted-by":"publisher","first-page":"854","DOI":"10.3348\/kjr.2022.0377","volume":"23","author":"A Esquivel","year":"2022","unstructured":"Esquivel A, Ferrero A, Mileto A, Baffour F, Horst K, Rajiah PS, et al. Photon-counting detector CT: key points radiologists should know. Korean J Radiol. 2022;23(9):854\u201365.","journal-title":"Korean J Radiol"},{"issue":"2","key":"1860_CR38","doi-asserted-by":"publisher","first-page":"e14270","DOI":"10.1002\/acm2.14270","volume":"25","author":"RT Sadia","year":"2024","unstructured":"Sadia RT, Chen J, Zhang J. CT image denoising methods for image quality improvement and radiation dose reduction. J Appl Clin Med Phys. 2024;25(2):e14270.","journal-title":"J Appl Clin Med Phys"},{"issue":"6","key":"1860_CR39","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1109\/TMI.2018.2827462","volume":"37","author":"Q Yang","year":"2018","unstructured":"Yang Q, Yan P, Zhang Y, Yu H, Shi Y, Mou X, et al. Low-dose CT image denoising using a generative adversarial network with Wasserstein distance and perceptual loss. IEEE Trans Med Imaging. 2018;37(6):1348\u201357.","journal-title":"IEEE Trans Med Imaging"},{"issue":"3","key":"1860_CR40","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/s00259-023-06481-0","volume":"51","author":"P Young","year":"2024","unstructured":"Young P, Heeman F, Axelsson J, Collij LE, Hitzel A, Sanaat A, et al. Impact of simulated reduced injected dose on the assessment of amyloid PET scans. Eur J Nucl Med Mol Imaging. 2024;51(3):734\u201348.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01860-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01860-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01860-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:22:07Z","timestamp":1759227727000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-025-01860-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1860"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01860-1","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"14 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the principle of the institutional and\/or national research committee and with the Declaration of Helsinki. Approval was granted by the institutional review board of Severance Hospital (IRB no. 2024-3483-001).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare the following financial interests and personal relationships, which may be considered as potential competing interests: Author Mijin Yun has equity in Newcure M, Inc. No other author has reported a potential conflict of interest relevant to this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"212"}}